• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.73% Nasdaq Down 0.96%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    7.67 Down 0.03(0.39%) 4:00PM EDT
    |After Hours : 7.67 0.00 (0.00%) 4:36PM EDT
    Add to Portfolio
    Prev Close:7.70
    Open:7.62
    Bid:7.58 x 400
    Ask:7.80 x 300
    1y Target Est:9.25
    Beta:1.6
    Next Earnings Date: 5-Aug-15ARIA Earnings announcement
    Day's Range:7.44 - 7.69
    52wk Range:4.90 - 9.89
    Volume:2,245,516
    Avg Vol (3m):3,357,820
    Market Cap:1.45B
    P/E (ttm):N/A
    EPS (ttm):-0.88
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARIA

    Comparison

    Symbol% ChgMkt Cap
    ARIADown 0.39%1.45B
    NVSDown 0.26%245.24B
    PFEUp 0.23%211.45B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.34
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.07
    Quarterly EPS Est (Jun-15) :-0.27
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-0.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback